41 – 50 of 61
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants
(
- Contribution to journal › Article
- 2013
-
Mark
Cholinergic and dopaminergic aspects of dementia in Parkinson's disease: postmortem neuropathological findings and modeling of cognitive dysfunction in rodents
(
- Thesis › Doctoral thesis (compilation)
-
Mark
What's to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?
(
- Contribution to journal › Article
-
Mark
Boosting chaperone-mediated autophagy in vivo mitigates alpha-synuclein-induced neurodegeneration
(
- Contribution to journal › Article
-
Mark
Animal Models of Parkinson's Disease: Limits and Relevance to Neuroprotection Studies
(
- Contribution to journal › Scientific review
-
Mark
LAMP2A as a therapeutic target in Parkinson disease
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease
(
- Contribution to journal › Article
- 2012
-
Mark
A Pilot Study Examining Associations between DYRK1A and alpha-Synuclein Dementias
(
- Contribution to journal › Article
-
Mark
Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.
(
- Contribution to journal › Article
-
Mark
Long-term polarization of microglia upon α-synuclein overexpression in nonhuman primates
(
- Contribution to journal › Article